NUS - NYSE
Nu Skin Enterprises, Inc.
$5.28
-5.7%Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
At a Glance
Live SnapshotNu Skin Enterprises, Inc. Management Team
Mr. Steven J. Lund J.D.
Co-Founder & Executive Chairman of the Board
Compensation
$725,749
Mr. James D. Thomas
Executive Vice President & Chief Financial Officer
Compensation
$1,477,585
Mr. Steven Keith Hatchett
Executive Vice President & Chief Product Officer
Compensation
$658,223
Dr. Joseph Y. Chang Ph.D.
Executive Vice President & Chief Scientific Officer
Compensation
$1,123,057
Mr. Chayce David Clark
Executive Vice President & General Counsel
Compensation
$1,816,355
Mr. Justin S. Keisel
Executive Vice President & President of Global Sales
Compensation
$591,618
Mr. Blake M. Roney
Founder
Compensation
$621,693
Ms. Sandra N. Tillotson
Founder
Compensation
$1,055,983
Mr. Ryan S. Napierski
President, Chief Executive Officer & Director
Compensation
$1,475,540
Mr. Joe Sueper
Senior Vice President & Chief Technology Officer
Nu Skin Enterprises, Inc. Insider Positioning
During the last 12 months, insiders have purchased $53K and sold $620K worth of NUS shares, resulting in $567K of net selling activity.
3 Months
0
0.00
2.7K
18.01K
-18K
-$18K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
5.5K
52.96K
0
0.00
+53K
+$53K
9-12 Months
0
0.00
49.9K
601.73K
-602K
-$602K
Top Buyers
Hatchett Steven Keith
Officer: Chief Product Officer
$53K
Woodbury Edwina D
Director
$103
Top Sellers
Campbell Daniel W
Director
$283K
Clark Chayce David
Officer: Evp And General Counsel
$239K
Nathanson Laura
Director
$97K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $567K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
3 insider sellers vs. 2 buyers. More insiders selling than buying suggests cautious or negative sentiment.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
NUS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 03, 2026 | May 28, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 04, 2025 | May 29, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 12, 2024 | June 05, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 14, 2023 | April 14, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 12, 2022 | June 02, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 12, 2021 | June 02, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 13, 2020 | June 03, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 17, 2019 | June 06, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 17, 2018 | June 07, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 17, 2017 | May 11, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.